TrialDiabetes & metabolism journal2024

Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial.

Jie-Eun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.